LYEL
Lyell Immunopharma·NASDAQ
--
--(--)
--
--(--)
LYEL fundamentals
Lyell Immunopharma (LYEL) released its earnings on Aug 12, 2025: revenue was 8.00K (YoY -38.46%), beat estimates; EPS was -2.89 (YoY +19.72%), beat estimates.
Revenue / YoY
8.00K
-38.46%
EPS / YoY
-2.89
+19.72%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 12, 2025
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
LYEL has released its 2025 Q4 earnings report, with revenue of 6.00K, reflecting a YoY change of -45.45%, and net profit of -140.72M, showing a YoY change of 26.68%. The Sankey diagram below clearly presents LYEL's revenue sources and cost distribution.
Key Indicators
Lyell Immunopharma (LYEL) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Lyell Immunopharma (LYEL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Lyell Immunopharma (LYEL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Lyell Immunopharma (LYEL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Lyell Immunopharma (LYEL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Lyell Immunopharma (LYEL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Lyell Immunopharma do and what are its main business segments?What is Lyell Immunopharma's latest dividend and current dividend yield?What guidance did Lyell Immunopharma's management provide for the next earnings period?What is the revenue and EPS growth rate for Lyell Immunopharma year over year?What were the key takeaways from Lyell Immunopharma’s earnings call?What were the key takeaways from Lyell Immunopharma's earnings call?Did Lyell Immunopharma beat or miss consensus estimates last quarter?What is the market's earnings forecast for Lyell Immunopharma next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
